Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Agilon Health, Inc. (AGL : NYSE)
 
 • Company Description   
agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States.

Number of Employees: 1,076

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.43 Daily Weekly Monthly
20 Day Moving Average: 3,185,178 shares
Shares Outstanding: 413.95 (millions)
Market Capitalization: $1,005.90 (millions)
Beta: 0.16
52 Week High: $7.73
52 Week Low: $1.50
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 15.71% 9.45%
12 Week -55.82% -62.93%
Year To Date 27.90% 19.79%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
440 Polaris Parkway Suite 550
-
Westerville,OH 43082
USA
ph: 562-256-3800
fax: -
investors@agilonhealth.com http://agilonhealth.com
 
 • General Corporate Information   
Officers
Steven J. Sell - Chief Executive Officer and President
Ronald A. Williams - Chairman
Ravi Sachdev - Vice Chairman
Jeffrey Schwaneke - Chief Financial Officer
Timothy Gertsch - Chief Accounting Officer

Peer Information
Agilon Health, Inc. (CHCR)
Agilon Health, Inc. (ESRX)
Agilon Health, Inc. (MYDP)
Agilon Health, Inc. (COR)
Agilon Health, Inc. (GBCS)
Agilon Health, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 00857U107
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
Share - Related Items
Shares Outstanding: 413.95
Most Recent Split Date: (:1)
Beta: 0.16
Market Capitalization: $1,005.90 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.10 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.36 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 27.51% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.01
Price/Cash Flow: -
Price / Sales: 0.17
EPS Growth
vs. Year Ago Period: -100.00%
vs. Previous Quarter: 100.00%
Sales Growth
vs. Year Ago Period: -4.46%
vs. Previous Quarter: 0.68%
ROE
06/30/25 - -
03/31/25 - -45.47
12/31/24 - -41.07
ROA
06/30/25 - -
03/31/25 - -12.76
12/31/24 - -11.92
Current Ratio
06/30/25 - -
03/31/25 - 1.20
12/31/24 - 1.27
Quick Ratio
06/30/25 - -
03/31/25 - 1.20
12/31/24 - 1.27
Operating Margin
06/30/25 - -
03/31/25 - -4.22
12/31/24 - -4.08
Net Margin
06/30/25 - -
03/31/25 - -4.04
12/31/24 - -4.29
Pre-Tax Margin
06/30/25 - -
03/31/25 - -4.24
12/31/24 - -4.11
Book Value
06/30/25 - -
03/31/25 - 1.21
12/31/24 - 1.14
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.07
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 6.90
 

Powered by Zacks Investment Research ©